Back to Search
DIANE J KELLY MD
MD
Obstetrics Physician
NPI: 1932190600Individual
Specialties, Licenses & Credentials
Obstetrics PhysicianPrimary
Obstetrics & Gynecology — Obstetrics
Code: 207VX0000X
ME47018(FL)
Research & Publications (20)
Protein kinase C-beta inhibition attenuates the progression of nephropathy in non-diabetic kidney disease.
PMID 19155535·Nephrol Dial Transplant·2009
7-preclinical
Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathy.
PMID 17720766·Am J Physiol Heart Circ Physiol·2007
7-preclinical
Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats.
PMID 17828524·Diabetologia·2007
7-preclinical
Combination therapy with tranilast and angiotensin-converting enzyme inhibition provides additional renoprotection in the remnant kidney model.
PMID 16557218·Kidney Int·2006
7-preclinical
Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy.
PMID 15843473·J Am Soc Nephrol·2005
7-preclinical
Cells expressing the stem cell factor receptor, c-kit, contribute to neoangiogenesis in diabetes.
PMID 16305063·Diab Vasc Dis Res·2005
7-preclinical
Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: attenuation with renin-angiotensin blockade.
PMID 14996301·Nephrology (Carlton)·2004
7-preclinical
Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model.
PMID 15466266·J Am Soc Nephrol·2004
4-observational
Platelet-derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivo.
PMID 15197170·Hypertension·2004
7-preclinical
Vascular endothelial growth factor expression and glomerular endothelial cell loss in the remnant kidney model.
PMID 12808163·Nephrol Dial Transplant·2003
7-preclinical
Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.
PMID 12540629·Diabetes·2003
7-preclinical
Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 rats.
PMID 11856772·J Am Soc Nephrol·2002
4-observational
Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats.
PMID 12032186·Nephrol Dial Transplant·2002
7-preclinical
Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.
PMID 12105259·Nephrol Dial Transplant·2002
7-preclinical
Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.
PMID 11562408·J Am Soc Nephrol·2001
7-preclinical
Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat.
PMID 10792607·Kidney Int·2000
7-preclinical
Implementing a personalized resource management program for a small medical library by using LinkOut.
PMID 16893849·Med Ref Serv Q·2006
8-other
Structure of the alpha-actinin-vinculin head domain complex determined by cryo-electron microscopy.
PMID 16430917·J Mol Biol·2006
7-preclinical
Identification of the beta1-integrin binding site on alpha-actinin by cryoelectron microscopy.
PMID 15721583·J Struct Biol·2005
7-preclinical
Pathophysiology of hypopituitarism in the setting of brain injury.
PMID 18481181·Pituitary·2012
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1223 GATEWAY DR
MELBOURNE, FL 32901 - Phone
- (321) 729-6166
Quick Facts
- NPI
- 1932190600
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile